Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for wrinkle reduction, but also in the treatment of debilitating medical conditions.
What you will learn from this webinar:
- Potential for Revance’s new, long-lasting neuromodulator product in aesthetics and therapeutics.
- Details on Revance’s premium dermal fillers and fintech services now launching into prestige dermatologic and plastic surgery practices.
- News on Revance’s program with Mylan to develop a biosimilar to BOTOX®.
BOTOX® is a registered trademark of Allergan, Inc.